2022-09-22-世界卫生组织-Global_Accelerator_for_Paediatric_Formulations_2022–2024_Business_Plan_56页_1mb

The Global Accelerator for Paediatric Formulations (GAP-f) 2022–2024 business plan outlines a strategic approach to improve pediatric medicines for children through three pillars: prioritize and align, accelerate, and intervene. GAP-f focuses on expanding therapeutic areas to include childhood cancer, neglected tropical diseases, and antimicrobial resistance, leveraging its experience from HIV, tuberculosis, and hepatitis C. The plan emphasizes transparent priority-setting, regulatory alignment, and capacity building. Key activities include developing clinical research tools, establishing a Pediatric Data Hub, and supporting targeted interventions for specific disease priorities like hepatitis C. GAP-f will coordinate partners, secure funding, and monitor progress through milestones, aiming to reduce child mortality by 2024. The budget is approximately $25 million, with a focus on innovative financing and resource mobilization.